155 related articles for article (PubMed ID: 29952992)
1. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
[TBL] [Abstract][Full Text] [Related]
2. Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.
Zhang BB; Wang DG; Xuan C; Sun GL; Deng KF
Fam Cancer; 2014 Dec; 13(4):515-26. PubMed ID: 24859942
[TBL] [Abstract][Full Text] [Related]
3. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
4. RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.
Cheng D; Shi H; Zhang K; Yi L; Zhen G
Diagn Pathol; 2014 Jan; 9():18. PubMed ID: 24457040
[TBL] [Abstract][Full Text] [Related]
5. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
Wang Z; Dong H; Fu Y; Ding H
Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
[TBL] [Abstract][Full Text] [Related]
6. Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
Wang W; Li JL; He XF; Li AP; Cai YL; Xu N; Sun SM; Wu BY
PLoS One; 2013; 8(9):e75153. PubMed ID: 24040396
[TBL] [Abstract][Full Text] [Related]
7. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Yu KD; Yang C; Fan L; Chen AX; Shao ZM
Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
[TBL] [Abstract][Full Text] [Related]
8. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
[TBL] [Abstract][Full Text] [Related]
9. 135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis.
Wu L; Long ZG; Dai ZS
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173193
[TBL] [Abstract][Full Text] [Related]
10. Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.
He YZ; Hu X; Chi XS; Zhang YC; Deng XB; Wei MT; Wang ZQ; Zhou YH
Tumour Biol; 2014 Jan; 35(1):615-21. PubMed ID: 23955800
[TBL] [Abstract][Full Text] [Related]
11. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
Sekhar D; Pooja S; Kumar S; Rajender S
Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
[TBL] [Abstract][Full Text] [Related]
12. RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a meta-analysis.
Hu X; Sun S
Int J Clin Exp Med; 2015; 8(12):22365-70. PubMed ID: 26885215
[TBL] [Abstract][Full Text] [Related]
13. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
[TBL] [Abstract][Full Text] [Related]
14. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
[TBL] [Abstract][Full Text] [Related]
15. RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
Zhou GW; Hu J; Peng XD; Li Q
Breast Cancer Res Treat; 2011 Jan; 125(2):529-35. PubMed ID: 20623332
[TBL] [Abstract][Full Text] [Related]
16. Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer.
Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Romanowicz H; Wilczak M
Pol J Pathol; 2013 Dec; 64(4):290-5. PubMed ID: 24375044
[TBL] [Abstract][Full Text] [Related]
17.
Yazdanpanahi N; Salehi R; Kamali S
J Cancer Res Ther; 2018; 14(3):614-618. PubMed ID: 29893328
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and ovarian cancer risk in Polish women.
Romanowicz-Makowska H; Smolarz B; Samulak D; Michalska M; Lewy J; Burzyński M; Kokołaszwili G
Eur J Gynaecol Oncol; 2012; 33(4):406-10. PubMed ID: 23091899
[TBL] [Abstract][Full Text] [Related]
19. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
[TBL] [Abstract][Full Text] [Related]
20.
Bali JS; Sambyal V; Guleria K; Mehrotra S; Singh NR; Uppal MS; Manjari M; Sudan M
J Cancer Res Ther; 2022 Dec; 18(Supplement):S273-S279. PubMed ID: 36510976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
